Hemogenyx Pharmaceuticals Plc HEMO.L Stock
Hemogenyx Pharmaceuticals Plc Price Chart
Hemogenyx Pharmaceuticals Plc HEMO.L Financial and Trading Overview
| Hemogenyx Pharmaceuticals Plc stock price | 1.62 GBP |
| Previous Close | 1.23 GBP |
| Open | 1.2 GBP |
| Bid | 1.25 GBP x 0 |
| Ask | 1.3 GBP x 0 |
| Day's Range | 1.2 - 1.3 GBP |
| 52 Week Range | 1.1 - 4.3 GBP |
| Volume | 2.92M GBP |
| Avg. Volume | 7.66M GBP |
| Market Cap | 15.11M GBP |
| Beta (5Y Monthly) | 3.659386 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 GBP |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
HEMO.L Valuation Measures
| Enterprise Value | 14.85M GBP |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 432.33334 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.8 |
Trading Information
Hemogenyx Pharmaceuticals Plc Stock Price History
| Beta (5Y Monthly) | 3.659386 |
| 52-Week Change | -19.31% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.3 GBP |
| 52 Week Low | 1.1 GBP |
| 50-Day Moving Average | 1.96 GBP |
| 200-Day Moving Average | 1.82 GBP |
HEMO.L Share Statistics
| Avg. Volume (3 month) | 7.66M GBP |
| Avg. Daily Volume (10-Days) | 18.2M GBP |
| Shares Outstanding | 1.14B |
| Float | 1.01B |
| Short Ratio | N/A |
| % Held by Insiders | 13.01% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -32.0050% |
| Return on Equity (ttm) | -69.87% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -3907581 GBP |
| Net Income Avi to Common (ttm) | -3979314 GBP |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.53M GBP |
| Total Cash Per Share (mrq) | 0.002 GBP |
| Total Debt (mrq) | 3.42M GBP |
| Total Debt/Equity (mrq) | 105.53 GBP |
| Current Ratio (mrq) | 3.467 |
| Book Value Per Share (mrq) | 0.003 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2910604 GBP |
| Levered Free Cash Flow (ttm) | -2394851 GBP |
Profile of Hemogenyx Pharmaceuticals Plc
| Country | United Kingdom |
| State | N/A |
| City | London |
| Address | 60 Gracechurch Street |
| ZIP | EC3V 0HR |
| Phone | N/A |
| Website | https://www.hemogenyx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 14 |
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML); HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal Hematopoietic Endothelial Cells, a stem cell therapy product for BM/HSC transplants. The company was founded in 2012 and is headquartered in London, the United Kingdom.
Q&A For Hemogenyx Pharmaceuticals Plc Stock
What is a current HEMO.L stock price?
Hemogenyx Pharmaceuticals Plc HEMO.L stock price today per share is 1.62 GBP.
How to purchase Hemogenyx Pharmaceuticals Plc stock?
You can buy HEMO.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hemogenyx Pharmaceuticals Plc?
The stock symbol or ticker of Hemogenyx Pharmaceuticals Plc is HEMO.L.
Which industry does the Hemogenyx Pharmaceuticals Plc company belong to?
The Hemogenyx Pharmaceuticals Plc industry is Biotechnology.
How many shares does Hemogenyx Pharmaceuticals Plc have in circulation?
The max supply of Hemogenyx Pharmaceuticals Plc shares is 13.42M.
What is Hemogenyx Pharmaceuticals Plc Price to Earnings Ratio (PE Ratio)?
Hemogenyx Pharmaceuticals Plc PE Ratio is now.
What was Hemogenyx Pharmaceuticals Plc earnings per share over the trailing 12 months (TTM)?
Hemogenyx Pharmaceuticals Plc EPS is -0.01 GBP over the trailing 12 months.
Which sector does the Hemogenyx Pharmaceuticals Plc company belong to?
The Hemogenyx Pharmaceuticals Plc sector is Healthcare.